Background and study aims : Although multiple HCV prevalence studies were recently performed in the general population from Belgium, they suffer from a lack of geographical representativeness, an insufficient number of participants or a lack of inclusion of high prevalence groups. The aim of this study is to provide robust information on the HCV burden. Methods : Recently performed HCV prevalence studies in the general, adult population were included in this study, based on well-defined selection criteria. A meta analysis was performed to estimate the seroprevalence, the prevalence of participants with viremia send the prevalence estimation for people with viremia which were unaware of their status. Results : Eight studies fulfilled the criteria for inclusion of the quantitative prevalence estimation. Based on the meta-analysis on these 8 studies, we estimated an HCV seroprevalence of 1.01% 195% CI : 0.66-1.42%], representing a total of 90,722 adult, HCV seropositives of which 64,412 individuals (0.71%) were confirmed seropositive. Based on the RNA presence, an estimated viremic prevalence of 0.33% I95% CI : 0.21-0.47 %1 was determined, corresponding with 29,642 individuals. This is 46,0% of the true HCV seropositive residents. Further, based on the availability of patient information in 5 out of the 8 studies, a prevalence of 0.18% 195% CI : 0.07-0.33J representing 16,168 individuals from the adult Belgian population are unaware of their HCV status. Conclusions: We believe that the quantitative measurement by the meta-analysis will be more reliable for their use in the design of a screening strategy or in the development of prevention campaigns as compared to the prevalence estimations performed at local level.